{"id":93701,"date":"2026-05-17T17:09:00","date_gmt":"2026-05-17T17:09:00","guid":{"rendered":"https:\/\/teeptrak.com\/trs-industrie-pharmaceutique-gmp-2026\/"},"modified":"2026-05-17T17:09:02","modified_gmt":"2026-05-17T17:09:02","slug":"trs-industrie-pharmaceutique-gmp-2026","status":"publish","type":"post","link":"https:\/\/teeptrak.com\/fr\/trs-industrie-pharmaceutique-gmp-2026\/","title":{"rendered":"TRS en industrie pharmaceutique 2026 : conformit\u00e9 GMP, 21 CFR Part 11 et data integrity"},"content":{"rendered":"<p>[et_pb_section fb_built=\u00a0\u00bb1&Prime; _builder_version=\u00a0\u00bb4.27&Prime;][et_pb_row _builder_version=\u00a0\u00bb4.27&Prime;][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.27&Prime;][et_pb_text _builder_version=\u00a0\u00bb4.27&Prime;]<\/p>\n<h1>TRS en industrie pharmaceutique 2026 : conformit\u00e9 GMP, 21 CFR Part 11 et data integrity<\/h1>\n<p><strong>Derni\u00e8re mise \u00e0 jour : 17 mai 2026.<\/strong> Le d\u00e9ploiement d&rsquo;une plateforme TRS en industrie pharmaceutique pr\u00e9sente une contrainte structurelle absente des autres secteurs : la conformit\u00e9 aux Good Manufacturing Practices (GMP) et aux r\u00e9glementations sur l&rsquo;int\u00e9grit\u00e9 des donn\u00e9es. Une plateforme TRS pertinente pour la production de comprim\u00e9s ou la mise en flacon st\u00e9rile ne peut pas se contenter de mesurer le TRS : elle doit le mesurer en respectant 21 CFR Part 11 (FDA), EU GMP Annex 11, et les principes ALCOA+ d&rsquo;int\u00e9grit\u00e9 des donn\u00e9es. Cet article documente les exigences sp\u00e9cifiques pharma et l&rsquo;architecture cible 2026.<\/p>\n<p>Les bases r\u00e9glementaires s&rsquo;appuient sur 21 CFR Part 11 (FDA, Electronic Records, Electronic Signatures), sur EU GMP Annex 11 (Computerised Systems), sur les guidelines ICH Q9 (Quality Risk Management) et ICH Q10 (Pharmaceutical Quality System), sur le PIC\/S guide PI 041-1 (Good Practices for Data Management and Integrity), et sur la norme ISO 22400-2:2014 pour les KPIs production. L&rsquo;exemple Nutriset (62 % \u00e0 80 % de TRS en 4 semaines) illustre la faisabilit\u00e9 en production nutritionnelle th\u00e9rapeutique (RUTF) sous contraintes qualit\u00e9 strictes.<\/p>\n<h2>Le cadre r\u00e9glementaire pharma applicable au TRS<\/h2>\n<h3>21 CFR Part 11 (FDA)<\/h3>\n<p>Norme am\u00e9ricaine r\u00e9gissant les enregistrements \u00e9lectroniques et les signatures \u00e9lectroniques en industrie pharmaceutique soumise \u00e0 la FDA. S&rsquo;applique \u00e0 tout syst\u00e8me collectant ou traitant des donn\u00e9es dans le cadre de proc\u00e9d\u00e9s GMP. Les exigences principales pour une plateforme TRS :<\/p>\n<ul>\n<li><strong>Audit trail complet<\/strong> : toute modification de donn\u00e9e trac\u00e9e avec utilisateur, horodatage, ancienne valeur, nouvelle valeur, raison.<\/li>\n<li><strong>Contr\u00f4le d&rsquo;acc\u00e8s<\/strong> : authentification utilisateur unique, gestion des r\u00f4les, s\u00e9paration des fonctions.<\/li>\n<li><strong>Signatures \u00e9lectroniques<\/strong> : pour les approbations critiques (d\u00e9viations, lib\u00e9ration de lots), conformes aux exigences Part 11 Subpart C.<\/li>\n<li><strong>Validation syst\u00e8me<\/strong> : d\u00e9monstration document\u00e9e que le syst\u00e8me fait ce qui est attendu (IQ\/OQ\/PQ).<\/li>\n<li><strong>Sauvegarde et archivage<\/strong> : pr\u00e9servation des donn\u00e9es sur la dur\u00e9e requise (typiquement 5-10 ans selon le produit).<\/li>\n<\/ul>\n<h3>EU GMP Annex 11 (EMA)<\/h3>\n<p>\u00c9quivalent europ\u00e9en de 21 CFR Part 11, structur\u00e9 diff\u00e9remment mais visant les m\u00eames objectifs. Couvre les syst\u00e8mes informatis\u00e9s en production pharma. Exigences principales : risk management document\u00e9, validation syst\u00e8me, qualification fournisseur, gestion des donn\u00e9es \u00e9lectroniques, audit trail, p\u00e9riodicit\u00e9 de revue.<\/p>\n<h3>Principes ALCOA+ d&rsquo;int\u00e9grit\u00e9 des donn\u00e9es<\/h3>\n<p>Les principes ALCOA, \u00e9tendus \u00e0 ALCOA+ par le PIC\/S guide PI 041-1, formalisent les attributs d&rsquo;int\u00e9grit\u00e9 des donn\u00e9es :<\/p>\n<table>\n<thead>\n<tr>\n<th>Lettre<\/th>\n<th>Attribut<\/th>\n<th>Application TRS<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>A<\/td>\n<td>Attributable<\/td>\n<td>Chaque donn\u00e9e trac\u00e9e \u00e0 un utilisateur identifi\u00e9 et horodat\u00e9<\/td>\n<\/tr>\n<tr>\n<td>L<\/td>\n<td>Legible<\/td>\n<td>Donn\u00e9es lisibles humainement et machine pendant toute la dur\u00e9e de conservation<\/td>\n<\/tr>\n<tr>\n<td>C<\/td>\n<td>Contemporaneous<\/td>\n<td>Donn\u00e9es enregistr\u00e9es au moment de l&rsquo;observation, pas a posteriori<\/td>\n<\/tr>\n<tr>\n<td>O<\/td>\n<td>Original<\/td>\n<td>Donn\u00e9es originales pr\u00e9serv\u00e9es (ou copie certifi\u00e9e), pas de r\u00e9\u00e9criture<\/td>\n<\/tr>\n<tr>\n<td>A<\/td>\n<td>Accurate<\/td>\n<td>Donn\u00e9es conformes \u00e0 la r\u00e9alit\u00e9, validation des saisies<\/td>\n<\/tr>\n<tr>\n<td>+C<\/td>\n<td>Complete<\/td>\n<td>Toutes les donn\u00e9es n\u00e9cessaires captur\u00e9es, pas de troncature<\/td>\n<\/tr>\n<tr>\n<td>+C<\/td>\n<td>Consistent<\/td>\n<td>Donn\u00e9es chronologiquement coh\u00e9rentes, pas d&rsquo;ant\u00e9riorit\u00e9<\/td>\n<\/tr>\n<tr>\n<td>+E<\/td>\n<td>Enduring<\/td>\n<td>P\u00e9rennit\u00e9 sur la dur\u00e9e requise (5-10 ans typique)<\/td>\n<\/tr>\n<tr>\n<td>+A<\/td>\n<td>Available<\/td>\n<td>Accessibilit\u00e9 \u00e0 l&rsquo;inspection et \u00e0 l&rsquo;audit<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Une plateforme TRS pharma doit d\u00e9montrer la conformit\u00e9 ALCOA+ \u00e0 chaque niveau : capteurs IIoT, transmission, stockage, pr\u00e9sentation, archivage. Cette exigence se traduit techniquement par audit trail syst\u00e9matique, horodatage NTP, signatures cryptographiques sur les exports, contr\u00f4les d&rsquo;int\u00e9grit\u00e9 p\u00e9riodiques.<\/p>\n<h2>La validation IQ\/OQ\/PQ d&rsquo;une plateforme TRS pharma<\/h2>\n<p>Toute plateforme informatis\u00e9e d\u00e9ploy\u00e9e en environnement GMP doit \u00eatre valid\u00e9e selon la m\u00e9thodologie IQ\/OQ\/PQ (Installation Qualification \/ Operational Qualification \/ Performance Qualification) :<\/p>\n<h3>IQ \u2014 Installation Qualification<\/h3>\n<p>V\u00e9rification document\u00e9e que l&rsquo;installation mat\u00e9rielle et logicielle est conforme aux sp\u00e9cifications. Inclut : inventaire mat\u00e9riel (capteurs, gateways, serveurs), versions logicielles, configurations r\u00e9seau, comptes utilisateurs, sauvegardes. Documentation typique : 30-60 pages, validation par 2-4 jours-homme assurance qualit\u00e9.<\/p>\n<h3>OQ \u2014 Operational Qualification<\/h3>\n<p>V\u00e9rification document\u00e9e que le syst\u00e8me fonctionne selon les sp\u00e9cifications op\u00e9rationnelles dans des conditions d\u00e9finies. Inclut : tests des fonctionnalit\u00e9s critiques (collecte capteurs, calcul TRS, audit trail, gestion utilisateurs, exports), tests aux limites (volume, charge), tests de d\u00e9faillance et reprise. Documentation typique : 60-150 pages selon complexit\u00e9, 8-15 jours-homme.<\/p>\n<h3>PQ \u2014 Performance Qualification<\/h3>\n<p>V\u00e9rification document\u00e9e que le syst\u00e8me r\u00e9pond aux besoins m\u00e9tier en conditions r\u00e9elles d&rsquo;utilisation. Inclut : production de lots tests, validation des KPIs calcul\u00e9s, validation des workflows de signature, validation des exports vers MES\/ERP. Documentation typique : 40-80 pages, 6-12 jours-homme sur 2-6 semaines.<\/p>\n<p>Le pack IQ\/OQ\/PQ complet repr\u00e9sente typiquement 15-30 jours-homme assurance qualit\u00e9 c\u00f4t\u00e9 pharma + 10-20 jours-homme c\u00f4t\u00e9 fournisseur de plateforme TRS. Co\u00fbt total typique 30 000-80 000 \u20ac pour un site, \u00e0 pond\u00e9rer sur la dur\u00e9e d&rsquo;exploitation (10-15 ans).<\/p>\n    <div class=\"teeptrak-form-container \">\n        <h3 class=\"teeptrak-form-title\">\u00c9tude de cas Nutriset : 62% \u00e0 80% de TRS en 4 semaines sous contraintes qualit\u00e9<\/h3>                \n        <form id=\"teeptrak-6a0a8c0892167\" class=\"teeptrak-form\" data-form-type=\"case_study\">\n            <div style=\"position:absolute;left:-9999px;\"><input type=\"text\" name=\"website_url\" value=\"\" tabindex=\"-1\"><input type=\"text\" name=\"fax_number\" value=\"\" tabindex=\"-1\"><\/div>            \n            <div class=\"teeptrak-form-row\">                <div class=\"teeptrak-form-field\">\n                    <label>Etude de cas <span class=\"required\">*<\/span><\/label>                    \n                                            <select name=\"case_study\" required>\n                                                            <option value=\"\">Selectionnez une etude de cas<\/option>\n                                                            <option value=\"Perftrak\">Perftrak<\/option>\n                                                            <option value=\"Etude de cas Secteur Materiaux\">Etude de cas Secteur Materiaux<\/option>\n                                                            <option value=\"Etude de cas Secteur Electronique\">Etude de cas Secteur Electronique<\/option>\n                                                            <option value=\"Etude de cas Secteur Automobile\">Etude de cas Secteur Automobile<\/option>\n                                                            <option value=\"Etude de cas Secteur Agroalimentaire\">Etude de cas Secteur Agroalimentaire<\/option>\n                                                    <\/select>\n                                    <\/div>\n            <\/div><div class=\"teeptrak-form-row teeptrak-form-row-half\">                <div class=\"teeptrak-form-field\">\n                    <label>Prenom <span class=\"required\">*<\/span><\/label>                    \n                                            <input type=\"text\" name=\"first_name\" required placeholder=\"\">\n                                    <\/div>\n                            <div class=\"teeptrak-form-field\">\n                    <label>Nom<\/label>                    \n                                            <input type=\"text\" name=\"last_name\"  placeholder=\"\">\n                                    <\/div>\n            <\/div><div class=\"teeptrak-form-row\">                <div class=\"teeptrak-form-field\">\n                    <label>Email <span class=\"required\">*<\/span><\/label>                    \n                                            <input type=\"email\" name=\"email\" required placeholder=\"\">\n                                    <\/div>\n            <\/div><div class=\"teeptrak-form-row\">                <div class=\"teeptrak-form-field\">\n                    <label>Entreprise<\/label>                    \n                                            <input type=\"text\" name=\"company\"  placeholder=\"\">\n                                    <\/div>\n            <\/div>            \n            <input type=\"hidden\" name=\"page_url\" value=\"https:\/\/teeptrak.com\/fr\/trs-industrie-pharmaceutique-gmp-2026\/\">\n            <input type=\"hidden\" name=\"recaptcha_token\" value=\"\" class=\"teeptrak-recaptcha-token\">\n            \n                        \n            <div class=\"teeptrak-form-row\">\n                <button type=\"submit\" class=\"teeptrak-submit teeptrak-submit-full\">\n                    <span class=\"teeptrak-submit-text\">T\u00e9l\u00e9charger l&#039;\u00e9tude de cas<\/span>\n                    <span class=\"teeptrak-submit-loading\" style=\"display:none;\">Envoi...<\/span>\n                <\/button>\n            <\/div>\n            \n            <div class=\"teeptrak-form-message\" style=\"display:none;\"><\/div>\n        <\/form>\n    <\/div>\n    \n<h2>Les sp\u00e9cificit\u00e9s TRS en production pharmaceutique<\/h2>\n<h3>Granularit\u00e9 par lot<\/h3>\n<p>La production pharma est structur\u00e9e par lots (batch records). Le TRS doit \u00eatre calcul\u00e9 par lot, pas en moyenne mensuelle. Le lot devient l&rsquo;unit\u00e9 de r\u00e9f\u00e9rence pour la lib\u00e9ration qualit\u00e9, la tra\u00e7abilit\u00e9, l&rsquo;analyse d&rsquo;\u00e9cart. La plateforme TRS doit donc capturer le lot ID en temps r\u00e9el et associer chaque mesure au lot correspondant.<\/p>\n<h3>Int\u00e9gration au batch record \u00e9lectronique (EBR)<\/h3>\n<p>Les donn\u00e9es TRS sont typiquement int\u00e9gr\u00e9es au batch record \u00e9lectronique (EBR) pour la revue de lib\u00e9ration de lot. Cette int\u00e9gration impose des formats standardis\u00e9s (typiquement S88\/ISA-88 pour les lots batch, ISA-95 pour les niveaux MES\/ERP).<\/p>\n<h3>Gestion des d\u00e9viations<\/h3>\n<p>En production pharma, toute d\u00e9viation par rapport au proc\u00e9d\u00e9 standard doit \u00eatre document\u00e9e, investigu\u00e9e, et sign\u00e9e par les fonctions qualit\u00e9. La plateforme TRS doit d\u00e9clencher automatiquement les d\u00e9viations sur seuils pr\u00e9d\u00e9finis (cadence anormalement basse, d\u00e9fauts qualit\u00e9 au-del\u00e0 du seuil, arr\u00eat non planifi\u00e9 au-del\u00e0 d&rsquo;une dur\u00e9e), avec workflow d&rsquo;investigation et signature.<\/p>\n<h3>Distinction temps GMP\/non-GMP<\/h3>\n<p>Tous les temps de production ne sont pas compt\u00e9s de la m\u00eame fa\u00e7on. Les temps de nettoyage entre lots (cleaning), de st\u00e9rilisation (sterilization), de validation proc\u00e9d\u00e9 (process validation) ont des r\u00e8gles de comptage sp\u00e9cifiques selon la GMP. La plateforme TRS doit mod\u00e9liser ces \u00e9tats distincts pour calculer un TRS pharma conforme aux pratiques sectorielles.<\/p>\n<h2>Les benchmarks TRS par typologie de production pharma<\/h2>\n<table>\n<thead>\n<tr>\n<th>Typologie<\/th>\n<th>TRS typique<\/th>\n<th>Sp\u00e9cificit\u00e9 dominante<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Formes solides (comprim\u00e9s, g\u00e9lules)<\/td>\n<td>55-75 %<\/td>\n<td>Changements fr\u00e9quents, granulation, compression, pelliculage<\/td>\n<\/tr>\n<tr>\n<td>Mise en flacon st\u00e9rile (filling)<\/td>\n<td>40-65 %<\/td>\n<td>Validation st\u00e9rilit\u00e9, faibles cadences, contraintes environnement<\/td>\n<\/tr>\n<tr>\n<td>Bulk API (principes actifs)<\/td>\n<td>60-80 %<\/td>\n<td>Proc\u00e9d\u00e9s continus, batch longs, peu de changements<\/td>\n<\/tr>\n<tr>\n<td>Conditionnement secondaire<\/td>\n<td>65-85 %<\/td>\n<td>S\u00e9rialisation (track and trace), changements fr\u00e9quents par r\u00e9f\u00e9rence<\/td>\n<\/tr>\n<tr>\n<td>Biologie \/ biotech (bior\u00e9acteurs)<\/td>\n<td>70-85 % (sur temps actif)<\/td>\n<td>Cycles longs, perte au d\u00e9marrage, maturation<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Ces benchmarks sont \u00e0 utiliser avec pr\u00e9caution : le TRS pharma int\u00e8gre des contraintes qualit\u00e9 (nettoyage valid\u00e9, st\u00e9rilisation, validation proc\u00e9d\u00e9) absentes des autres secteurs, qui structurellement plafonnent le TRS. Comparer un TRS pharma \u00e0 un TRS automobile sans correction n&rsquo;est pas pertinent.<\/p>\n<h2>Les 5 erreurs fr\u00e9quentes du d\u00e9ploiement TRS pharma<\/h2>\n<ol>\n<li><strong>Choisir une plateforme TRS non validable<\/strong>. Une plateforme non con\u00e7ue pour Part 11\/Annex 11 ne peut pas \u00eatre rendue conforme par customisation. La validation IQ\/OQ\/PQ se heurte \u00e0 des limitations structurelles. Le choix initial doit imposer la conformit\u00e9 native.<\/li>\n<li><strong>Sous-estimer la dur\u00e9e de validation<\/strong>. La validation IQ\/OQ\/PQ ajoute typiquement 3-6 mois au calendrier de d\u00e9ploiement initial. Les projets pharma qui sautent ou abr\u00e8gent la validation rencontrent ensuite des blocages r\u00e9glementaires lourds.<\/li>\n<li><strong>Ignorer l&rsquo;audit trail des modifications<\/strong>. Toute modification de param\u00e8tre TRS (cadence nominale, seuils alarme, classification d&rsquo;arr\u00eat) doit \u00eatre trac\u00e9e avec utilisateur, horodatage, raison. Sans cet audit trail, la plateforme est non Part 11 compliant.<\/li>\n<li><strong>Confondre TRS pharma et TRS automotive<\/strong>. Le TRS pharma int\u00e8gre des temps de nettoyage et st\u00e9rilisation qui plafonnent structurellement le r\u00e9sultat. Appliquer m\u00e9caniquement des benchmarks automobile conduit \u00e0 des objectifs irr\u00e9alistes et d\u00e9motivants.<\/li>\n<li><strong>Sous-estimer la formation des op\u00e9rateurs<\/strong>. La d\u00e9claration des causes d&rsquo;arr\u00eat en environnement GMP n\u00e9cessite formation et habilitation. Les op\u00e9rateurs non form\u00e9s produisent des d\u00e9clarations incoh\u00e9rentes qui d\u00e9gradent la qualit\u00e9 des donn\u00e9es et compromettent l&rsquo;audit data integrity.<\/li>\n<\/ol>\n<h2>D\u00e9marrer un projet TRS pharma sous contraintes GMP<\/h2>\n<p>La m\u00e9thode pragmatique pour d\u00e9marrer en 2026 : pr\u00e9-audit data integrity du site, s\u00e9lection d&rsquo;une plateforme TRS nativement Part 11\/Annex 11, POC valid\u00e9 sur 1-3 \u00e9quipements repr\u00e9sentatifs (typiquement 2-4 mois avec validation incluse), extension progressive avec qualification de chaque nouvelle ligne. Cette approche progressive limite le risque et construit la confiance assurance qualit\u00e9.<\/p>\n    <div class=\"teeptrak-form-container \">\n        <h3 class=\"teeptrak-form-title\">D\u00e9mo TRS pharma + GMP : 45 min \u2014 Part 11\/Annex 11 compliant<\/h3>                \n        <form id=\"teeptrak-6a0a8c08921ee\" class=\"teeptrak-form\" data-form-type=\"demo_request\">\n            <div style=\"position:absolute;left:-9999px;\"><input type=\"text\" name=\"website_url\" value=\"\" tabindex=\"-1\"><input type=\"text\" name=\"fax_number\" value=\"\" tabindex=\"-1\"><\/div>            \n            <div class=\"teeptrak-form-row teeptrak-form-row-half\">                <div class=\"teeptrak-form-field\">\n                    <label>Prenom <span class=\"required\">*<\/span><\/label>                    \n                                            <input type=\"text\" name=\"first_name\" required placeholder=\"\">\n                                    <\/div>\n                            <div class=\"teeptrak-form-field\">\n                    <label>Nom <span class=\"required\">*<\/span><\/label>                    \n                                            <input type=\"text\" name=\"last_name\" required placeholder=\"\">\n                                    <\/div>\n                            <div class=\"teeptrak-form-field\">\n                    <label>Email <span class=\"required\">*<\/span><\/label>                    \n                                            <input type=\"email\" name=\"email\" required placeholder=\"\">\n                                    <\/div>\n                            <div class=\"teeptrak-form-field\">\n                    <label>Telephone <span class=\"required\">*<\/span><\/label>                    \n                                            <input type=\"tel\" name=\"phone\" required placeholder=\"\">\n                                    <\/div>\n                            <div class=\"teeptrak-form-field\">\n                    <label>Entreprise <span class=\"required\">*<\/span><\/label>                    \n                                            <input type=\"text\" name=\"company\" required placeholder=\"\">\n                                    <\/div>\n                            <div class=\"teeptrak-form-field\">\n                    <label>Poste<\/label>                    \n                                            <input type=\"text\" name=\"job_title\"  placeholder=\"\">\n                                    <\/div>\n            <\/div><div class=\"teeptrak-form-row\">                <div class=\"teeptrak-form-field\">\n                    <label>Objectifs<\/label>                    \n                                            <textarea name=\"message\" rows=\"3\"  placeholder=\"\"><\/textarea>\n                                    <\/div>\n            <\/div>            \n            <input type=\"hidden\" name=\"page_url\" value=\"https:\/\/teeptrak.com\/fr\/trs-industrie-pharmaceutique-gmp-2026\/\">\n            <input type=\"hidden\" name=\"recaptcha_token\" value=\"\" class=\"teeptrak-recaptcha-token\">\n            \n                        \n            <div class=\"teeptrak-form-row\">\n                <button type=\"submit\" class=\"teeptrak-submit teeptrak-submit-full\">\n                    <span class=\"teeptrak-submit-text\">R\u00e9server une d\u00e9mo<\/span>\n                    <span class=\"teeptrak-submit-loading\" style=\"display:none;\">Envoi...<\/span>\n                <\/button>\n            <\/div>\n            \n            <div class=\"teeptrak-form-message\" style=\"display:none;\"><\/div>\n        <\/form>\n    <\/div>\n    \n<h2>Questions fr\u00e9quentes<\/h2>\n<h3>Qu&rsquo;est-ce que le TRS en industrie pharmaceutique ?<\/h3>\n<p>Mesure du Taux de Rendement Synth\u00e9tique (Disponibilit\u00e9 \u00d7 Performance \u00d7 Qualit\u00e9 selon ISO 22400-2:2014) appliqu\u00e9e \u00e0 la production pharma, avec contraintes sp\u00e9cifiques de conformit\u00e9 GMP : 21 CFR Part 11 (FDA), EU GMP Annex 11 (EMA), int\u00e9grit\u00e9 des donn\u00e9es ALCOA+, validation syst\u00e8me IQ\/OQ\/PQ.<\/p>\n<h3>Qu&rsquo;est-ce que 21 CFR Part 11 ?<\/h3>\n<p>Norme FDA am\u00e9ricaine r\u00e9gissant enregistrements \u00e9lectroniques et signatures \u00e9lectroniques en industrie pharmaceutique. Exigences : audit trail complet, contr\u00f4le d&rsquo;acc\u00e8s, signatures \u00e9lectroniques, validation syst\u00e8me, sauvegarde et archivage 5-10 ans selon produit.<\/p>\n<h3>Qu&rsquo;est-ce que EU GMP Annex 11 ?<\/h3>\n<p>\u00c9quivalent europ\u00e9en de 21 CFR Part 11 par EMA, structur\u00e9 diff\u00e9remment mais visant m\u00eames objectifs. Couvre syst\u00e8mes informatis\u00e9s en production pharma : risk management, validation syst\u00e8me, qualification fournisseur, gestion donn\u00e9es \u00e9lectroniques, audit trail.<\/p>\n<h3>Quels sont les principes ALCOA+ ?<\/h3>\n<p>Attributs d&rsquo;int\u00e9grit\u00e9 des donn\u00e9es formalis\u00e9s par PIC\/S PI 041-1 : Attributable, Legible, Contemporaneous, Original, Accurate, +Complete, Consistent, Enduring, Available. Une plateforme TRS pharma doit d\u00e9montrer conformit\u00e9 ALCOA+ \u00e0 chaque niveau.<\/p>\n<h3>Qu&rsquo;est-ce que la validation IQ\/OQ\/PQ ?<\/h3>\n<p>Installation Qualification (v\u00e9rification installation conforme aux sp\u00e9cifications), Operational Qualification (v\u00e9rification fonctionnement selon sp\u00e9cifications), Performance Qualification (v\u00e9rification en conditions r\u00e9elles d&rsquo;utilisation). 15-30 jours-homme AQ + 10-20 jours-homme fournisseur, 30 000-80 000 \u20ac pour un site.<\/p>\n<h3>Quel TRS typique en industrie pharmaceutique ?<\/h3>\n<p>Formes solides 55-75 %, mise en flacon st\u00e9rile 40-65 %, bulk API 60-80 %, conditionnement secondaire 65-85 %, biotech bior\u00e9acteurs 70-85 % sur temps actif. Benchmarks inf\u00e9rieurs \u00e0 industrie automobile en raison contraintes qualit\u00e9 (nettoyage, st\u00e9rilisation, validation).<\/p>\n<h3>Faut-il un TRS par lot en pharma ?<\/h3>\n<p>Oui. La production pharma est structur\u00e9e par lots (batch records) qui sont l&rsquo;unit\u00e9 de r\u00e9f\u00e9rence pour lib\u00e9ration qualit\u00e9, tra\u00e7abilit\u00e9, analyse d&rsquo;\u00e9cart. La plateforme TRS doit capturer le lot ID en temps r\u00e9el et associer chaque mesure au lot.<\/p>\n<h3>Comment int\u00e9grer TRS et batch record \u00e9lectronique (EBR) ?<\/h3>\n<p>Donn\u00e9es TRS int\u00e9gr\u00e9es au batch record \u00e9lectronique pour revue de lib\u00e9ration de lot. Standards d&rsquo;int\u00e9gration : S88\/ISA-88 pour lots batch, ISA-95 pour niveaux MES\/ERP. Workflow d&rsquo;approbation avec signatures \u00e9lectroniques Part 11 compliant.<\/p>\n<h3>Comment g\u00e9rer les d\u00e9viations TRS en pharma ?<\/h3>\n<p>Plateforme TRS doit d\u00e9clencher automatiquement d\u00e9viations sur seuils pr\u00e9d\u00e9finis (cadence anormale, d\u00e9fauts qualit\u00e9, arr\u00eat non planifi\u00e9), avec workflow investigation et signature. Toute d\u00e9viation document\u00e9e, investigu\u00e9e, sign\u00e9e par fonctions qualit\u00e9.<\/p>\n<h3>Quelle est l&rsquo;erreur la plus fr\u00e9quente en projet TRS pharma ?<\/h3>\n<p>Choisir une plateforme TRS non nativement Part 11\/Annex 11 compliant. Plateforme non con\u00e7ue pour validation se heurte \u00e0 limitations structurelles non corrigeables par customisation. Le choix initial doit imposer conformit\u00e9 native, pas a posteriori.<\/p>\n<p><em>Auteur : Fran\u00e7ois Coulloudon, CEO, TeepTrak. Relecture : Bastien Affeltranger, CTO. R\u00e9f\u00e9rences crois\u00e9es : <a href=\"https:\/\/teeptrak.com\/trs-industrie-agroalimentaire-ifs-brc-2026\/\">TRS industrie agroalimentaire IFS BRC<\/a>, <a href=\"https:\/\/teeptrak.com\/fr\/six-big-losses-trs-2026\/\">Six Big Losses et TRS<\/a>, <a href=\"https:\/\/teeptrak.com\/fr\/mttr-mtbf-mtta-2026\/\">MTTR MTBF MTTA KPIs maintenance<\/a>. Derni\u00e8re v\u00e9rification : 17 mai 2026 contre 21 CFR Part 11, EU GMP Annex 11, ICH Q9\/Q10, PIC\/S PI 041-1.<\/em><\/p>\n<p><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/teeptrak.com\/trs-industrie-pharmaceutique-gmp-2026\/#article\",\"headline\":\"TRS en industrie pharmaceutique 2026 : conformit\u00e9 GMP, 21 CFR Part 11 et data integrity\",\"datePublished\":\"2026-05-17\",\"dateModified\":\"2026-05-17\",\"inLanguage\":\"fr-FR\",\"author\":{\"@type\":\"Organization\",\"name\":\"TeepTrak\",\"url\":\"https:\/\/teeptrak.com\/\"},\"publisher\":{\"@id\":\"https:\/\/teeptrak.com\/#organization\"},\"mainEntityOfPage\":\"https:\/\/teeptrak.com\/trs-industrie-pharmaceutique-gmp-2026\/\",\"citation\":[{\"@type\":\"CreativeWork\",\"name\":\"21 CFR Part 11\",\"url\":\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?CFRPart=11\"},{\"@type\":\"CreativeWork\",\"name\":\"EU GMP Annex 11\",\"url\":\"https:\/\/health.ec.europa.eu\/system\/files\/2016-11\/annex11_01-2011_en_0.pdf\"},{\"@type\":\"CreativeWork\",\"name\":\"PIC\/S PI 041-1\",\"url\":\"https:\/\/picscheme.org\/\"},{\"@type\":\"CreativeWork\",\"name\":\"ISO 22400-2:2014\",\"url\":\"https:\/\/www.iso.org\/standard\/54497.html\"},{\"@type\":\"CreativeWork\",\"name\":\"ICH Q9\",\"url\":\"https:\/\/www.ich.org\/page\/quality-guidelines\"},{\"@type\":\"CreativeWork\",\"name\":\"ICH Q10\",\"url\":\"https:\/\/www.ich.org\/page\/quality-guidelines\"}]},{\"@type\":\"FAQPage\",\"@id\":\"https:\/\/teeptrak.com\/trs-industrie-pharmaceutique-gmp-2026\/#faq\",\"inLanguage\":\"fr-FR\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Qu'est-ce que le TRS en industrie pharmaceutique ?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Mesure du Taux de Rendement Synth\u00e9tique (Disponibilit\u00e9 \u00d7 Performance \u00d7 Qualit\u00e9 selon ISO 22400-2:2014) appliqu\u00e9e \u00e0 la production pharma, avec contraintes GMP : 21 CFR Part 11 FDA, EU GMP Annex 11 EMA, int\u00e9grit\u00e9 donn\u00e9es ALCOA+, validation IQ\/OQ\/PQ.\"}},{\"@type\":\"Question\",\"name\":\"Qu'est-ce que 21 CFR Part 11 ?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Norme FDA r\u00e9gissant enregistrements et signatures \u00e9lectroniques en pharma. Exigences : audit trail complet, contr\u00f4le d'acc\u00e8s, signatures \u00e9lectroniques, validation syst\u00e8me, sauvegarde 5-10 ans selon produit.\"}},{\"@type\":\"Question\",\"name\":\"Qu'est-ce que EU GMP Annex 11 ?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"\u00c9quivalent europ\u00e9en de 21 CFR Part 11 par EMA. Couvre syst\u00e8mes informatis\u00e9s en production pharma : risk management, validation syst\u00e8me, qualification fournisseur, gestion donn\u00e9es \u00e9lectroniques, audit trail.\"}},{\"@type\":\"Question\",\"name\":\"Quels sont les principes ALCOA+ ?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Attributs d'int\u00e9grit\u00e9 des donn\u00e9es (PIC\/S PI 041-1) : Attributable, Legible, Contemporaneous, Original, Accurate, +Complete, Consistent, Enduring, Available. Plateforme TRS pharma doit d\u00e9montrer conformit\u00e9 ALCOA+ \u00e0 chaque niveau.\"}},{\"@type\":\"Question\",\"name\":\"Qu'est-ce que la validation IQ\/OQ\/PQ ?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Installation Qualification (installation conforme sp\u00e9cifications), Operational Qualification (fonctionnement selon sp\u00e9cifications), Performance Qualification (conditions r\u00e9elles d'utilisation). 15-30 jours-homme AQ + 10-20 jours-homme fournisseur, 30 000-80 000 \u20ac par site.\"}},{\"@type\":\"Question\",\"name\":\"Quel TRS typique en industrie pharmaceutique ?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Formes solides 55-75 pourcent, mise en flacon st\u00e9rile 40-65 pourcent, bulk API 60-80 pourcent, conditionnement secondaire 65-85 pourcent, biotech 70-85 pourcent sur temps actif. Inf\u00e9rieur \u00e0 automotive par contraintes qualit\u00e9.\"}},{\"@type\":\"Question\",\"name\":\"Faut-il un TRS par lot en pharma ?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Oui. Production pharma structur\u00e9e par lots (batch records) unit\u00e9 de r\u00e9f\u00e9rence lib\u00e9ration qualit\u00e9, tra\u00e7abilit\u00e9, analyse d'\u00e9cart. Plateforme TRS doit capturer lot ID temps r\u00e9el et associer chaque mesure au lot.\"}},{\"@type\":\"Question\",\"name\":\"Comment int\u00e9grer TRS et batch record \u00e9lectronique (EBR) ?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Donn\u00e9es TRS int\u00e9gr\u00e9es au batch record \u00e9lectronique pour revue lib\u00e9ration de lot. Standards : S88\/ISA-88 pour lots batch, ISA-95 pour niveaux MES\/ERP. Workflow approbation avec signatures \u00e9lectroniques Part 11.\"}},{\"@type\":\"Question\",\"name\":\"Comment g\u00e9rer les d\u00e9viations TRS en pharma ?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Plateforme TRS d\u00e9clenche automatiquement d\u00e9viations sur seuils (cadence anormale, d\u00e9fauts qualit\u00e9, arr\u00eat non planifi\u00e9), avec workflow investigation et signature. D\u00e9viation document\u00e9e, investigu\u00e9e, sign\u00e9e par fonctions qualit\u00e9.\"}},{\"@type\":\"Question\",\"name\":\"Quelle est l'erreur la plus fr\u00e9quente en projet TRS pharma ?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Choisir plateforme TRS non nativement Part 11\/Annex 11 compliant. Plateforme non con\u00e7ue pour validation se heurte \u00e0 limitations structurelles non corrigeables par customisation. Choix initial doit imposer conformit\u00e9 native.\"}}]}]}<\/script><br \/>\n[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[et_pb_section fb_built=\u00a0\u00bb1&Prime; _builder_version=\u00a0\u00bb4.27&Prime;][et_pb_row _builder_version=\u00a0\u00bb4.27&Prime;][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.27&Prime;][et_pb_text _builder_version=\u00a0\u00bb4.27&Prime;] TRS en industrie pharmaceutique 2026 : conformit\u00e9 GMP, 21 CFR Part 11 et data integrity Derni\u00e8re mise \u00e0 jour : 17 mai 2026. Le d\u00e9ploiement d&rsquo;une plateforme TRS en industrie pharmaceutique pr\u00e9sente une contrainte structurelle absente des autres secteurs : la conformit\u00e9 aux Good Manufacturing Practices (GMP) et [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":93695,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","ai_seo_title":"TRS pharma 2026 : GMP + 21 CFR Part 11 + ALCOA+ data integrity | TeepTrak","ai_meta_description":"Guide complet 2026 de la mesure TRS en industrie pharmaceutique : conformit\u00e9 EU GMP Annex 11 et FDA 21 CFR Part 11, principes ALCOA+ data integrity, validation syst\u00e8me (IQ\/OQ\/PQ), audit trail. Cadre ISO 22400-2:2014.","ai_focus_keyword":"TRS industrie pharmaceutique","footnotes":""},"categories":[1],"tags":[],"class_list":["post-93701","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>TRS pharma 2026 : GMP + 21 CFR Part 11 + ALCOA+ data integrity | TeepTrak<\/title>\n<meta name=\"description\" content=\"Guide complet 2026 de la mesure TRS en industrie pharmaceutique : conformit\u00e9 EU GMP Annex 11 et FDA 21 CFR Part 11, principes ALCOA+ data integrity, validation syst\u00e8me (IQ\/OQ\/PQ), audit trail. Cadre ISO 22400-2:2014.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/teeptrak.com\/fr\/trs-industrie-pharmaceutique-gmp-2026\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TRS pharma 2026 : GMP + 21 CFR Part 11 + ALCOA+ data integrity | TeepTrak\" \/>\n<meta property=\"og:description\" content=\"Guide complet 2026 de la mesure TRS en industrie pharmaceutique : conformit\u00e9 EU GMP Annex 11 et FDA 21 CFR Part 11, principes ALCOA+ data integrity, validation syst\u00e8me (IQ\/OQ\/PQ), audit trail. Cadre ISO 22400-2:2014.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/teeptrak.com\/fr\/trs-industrie-pharmaceutique-gmp-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"TEEPTRAK - Connect to your industrial potential\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-17T17:09:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-17T17:09:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/teeptrak.com\/wp-content\/uploads\/2026\/05\/trs-industrie-pharmaceutique-gmp-2026.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1150\" \/>\n\t<meta property=\"og:image:height\" content=\"657\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"\u00c9quipe TEEPTRAK\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u00c9quipe TEEPTRAK\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"10 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/teeptrak.com\\\/fr\\\/trs-industrie-pharmaceutique-gmp-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/teeptrak.com\\\/fr\\\/trs-industrie-pharmaceutique-gmp-2026\\\/\"},\"author\":{\"name\":\"\u00c9quipe TEEPTRAK\",\"@id\":\"https:\\\/\\\/teeptrak.com\\\/fr\\\/#\\\/schema\\\/person\\\/e0b65287bf97c0856b9e70813a4b5aff\"},\"headline\":\"TRS en industrie pharmaceutique 2026 : conformit\u00e9 GMP, 21 CFR Part 11 et data integrity\",\"datePublished\":\"2026-05-17T17:09:00+00:00\",\"dateModified\":\"2026-05-17T17:09:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/teeptrak.com\\\/fr\\\/trs-industrie-pharmaceutique-gmp-2026\\\/\"},\"wordCount\":2060,\"publisher\":{\"@id\":\"https:\\\/\\\/teeptrak.com\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/teeptrak.com\\\/fr\\\/trs-industrie-pharmaceutique-gmp-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/teeptrak.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/trs-industrie-pharmaceutique-gmp-2026.jpeg\",\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/teeptrak.com\\\/fr\\\/trs-industrie-pharmaceutique-gmp-2026\\\/\",\"url\":\"https:\\\/\\\/teeptrak.com\\\/fr\\\/trs-industrie-pharmaceutique-gmp-2026\\\/\",\"name\":\"TRS pharma 2026 : GMP + 21 CFR Part 11 + ALCOA+ data integrity | TeepTrak\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/teeptrak.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/teeptrak.com\\\/fr\\\/trs-industrie-pharmaceutique-gmp-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/teeptrak.com\\\/fr\\\/trs-industrie-pharmaceutique-gmp-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/teeptrak.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/trs-industrie-pharmaceutique-gmp-2026.jpeg\",\"datePublished\":\"2026-05-17T17:09:00+00:00\",\"dateModified\":\"2026-05-17T17:09:02+00:00\",\"description\":\"Guide complet 2026 de la mesure TRS en industrie pharmaceutique : conformit\u00e9 EU GMP Annex 11 et FDA 21 CFR Part 11, principes ALCOA+ data integrity, validation syst\u00e8me (IQ\\\/OQ\\\/PQ), audit trail. Cadre ISO 22400-2:2014.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/teeptrak.com\\\/fr\\\/trs-industrie-pharmaceutique-gmp-2026\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/teeptrak.com\\\/fr\\\/trs-industrie-pharmaceutique-gmp-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/teeptrak.com\\\/fr\\\/trs-industrie-pharmaceutique-gmp-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/teeptrak.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/trs-industrie-pharmaceutique-gmp-2026.jpeg\",\"contentUrl\":\"https:\\\/\\\/teeptrak.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/trs-industrie-pharmaceutique-gmp-2026.jpeg\",\"width\":1150,\"height\":657,\"caption\":\"TRS pharma 2026 : GMP + 21 CFR Part 11 + ALCOA+ data integrity | TeepTrak\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/teeptrak.com\\\/fr\\\/trs-industrie-pharmaceutique-gmp-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/teeptrak.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TRS en industrie pharmaceutique 2026 : conformit\u00e9 GMP, 21 CFR Part 11 et data integrity\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/teeptrak.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/teeptrak.com\\\/fr\\\/\",\"name\":\"TEEPTRAK\",\"description\":\"Optimisez votre potentiel industriel\",\"publisher\":{\"@id\":\"https:\\\/\\\/teeptrak.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/teeptrak.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/teeptrak.com\\\/fr\\\/#organization\",\"name\":\"TEEPTRAK\",\"url\":\"https:\\\/\\\/teeptrak.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/teeptrak.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/teeptrak.com\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/cropped-Capture-decran-2023-05-04-112832.png\",\"contentUrl\":\"https:\\\/\\\/teeptrak.com\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/cropped-Capture-decran-2023-05-04-112832.png\",\"width\":512,\"height\":512,\"caption\":\"TEEPTRAK\"},\"image\":{\"@id\":\"https:\\\/\\\/teeptrak.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/teeptrak\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/teeptrakinternational\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/teeptrak.com\\\/fr\\\/#\\\/schema\\\/person\\\/e0b65287bf97c0856b9e70813a4b5aff\",\"name\":\"\u00c9quipe TEEPTRAK\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c15a5bed2b22793c34b357757ed5a12321e733893599e115e40c0263ef4877f7?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c15a5bed2b22793c34b357757ed5a12321e733893599e115e40c0263ef4877f7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c15a5bed2b22793c34b357757ed5a12321e733893599e115e40c0263ef4877f7?s=96&d=mm&r=g\",\"caption\":\"\u00c9quipe TEEPTRAK\"},\"sameAs\":[\"https:\\\/\\\/teeptrak.com\"],\"url\":\"https:\\\/\\\/teeptrak.com\\\/fr\\\/author\\\/auriane\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TRS pharma 2026 : GMP + 21 CFR Part 11 + ALCOA+ data integrity | TeepTrak","description":"Guide complet 2026 de la mesure TRS en industrie pharmaceutique : conformit\u00e9 EU GMP Annex 11 et FDA 21 CFR Part 11, principes ALCOA+ data integrity, validation syst\u00e8me (IQ\/OQ\/PQ), audit trail. Cadre ISO 22400-2:2014.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/teeptrak.com\/fr\/trs-industrie-pharmaceutique-gmp-2026\/","og_locale":"fr_FR","og_type":"article","og_title":"TRS pharma 2026 : GMP + 21 CFR Part 11 + ALCOA+ data integrity | TeepTrak","og_description":"Guide complet 2026 de la mesure TRS en industrie pharmaceutique : conformit\u00e9 EU GMP Annex 11 et FDA 21 CFR Part 11, principes ALCOA+ data integrity, validation syst\u00e8me (IQ\/OQ\/PQ), audit trail. Cadre ISO 22400-2:2014.","og_url":"https:\/\/teeptrak.com\/fr\/trs-industrie-pharmaceutique-gmp-2026\/","og_site_name":"TEEPTRAK - Connect to your industrial potential","article_published_time":"2026-05-17T17:09:00+00:00","article_modified_time":"2026-05-17T17:09:02+00:00","og_image":[{"width":1150,"height":657,"url":"https:\/\/teeptrak.com\/wp-content\/uploads\/2026\/05\/trs-industrie-pharmaceutique-gmp-2026.jpeg","type":"image\/jpeg"}],"author":"\u00c9quipe TEEPTRAK","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"\u00c9quipe TEEPTRAK","Dur\u00e9e de lecture estim\u00e9e":"10 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/teeptrak.com\/fr\/trs-industrie-pharmaceutique-gmp-2026\/#article","isPartOf":{"@id":"https:\/\/teeptrak.com\/fr\/trs-industrie-pharmaceutique-gmp-2026\/"},"author":{"name":"\u00c9quipe TEEPTRAK","@id":"https:\/\/teeptrak.com\/fr\/#\/schema\/person\/e0b65287bf97c0856b9e70813a4b5aff"},"headline":"TRS en industrie pharmaceutique 2026 : conformit\u00e9 GMP, 21 CFR Part 11 et data integrity","datePublished":"2026-05-17T17:09:00+00:00","dateModified":"2026-05-17T17:09:02+00:00","mainEntityOfPage":{"@id":"https:\/\/teeptrak.com\/fr\/trs-industrie-pharmaceutique-gmp-2026\/"},"wordCount":2060,"publisher":{"@id":"https:\/\/teeptrak.com\/fr\/#organization"},"image":{"@id":"https:\/\/teeptrak.com\/fr\/trs-industrie-pharmaceutique-gmp-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/teeptrak.com\/wp-content\/uploads\/2026\/05\/trs-industrie-pharmaceutique-gmp-2026.jpeg","articleSection":["Uncategorized"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/teeptrak.com\/fr\/trs-industrie-pharmaceutique-gmp-2026\/","url":"https:\/\/teeptrak.com\/fr\/trs-industrie-pharmaceutique-gmp-2026\/","name":"TRS pharma 2026 : GMP + 21 CFR Part 11 + ALCOA+ data integrity | TeepTrak","isPartOf":{"@id":"https:\/\/teeptrak.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/teeptrak.com\/fr\/trs-industrie-pharmaceutique-gmp-2026\/#primaryimage"},"image":{"@id":"https:\/\/teeptrak.com\/fr\/trs-industrie-pharmaceutique-gmp-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/teeptrak.com\/wp-content\/uploads\/2026\/05\/trs-industrie-pharmaceutique-gmp-2026.jpeg","datePublished":"2026-05-17T17:09:00+00:00","dateModified":"2026-05-17T17:09:02+00:00","description":"Guide complet 2026 de la mesure TRS en industrie pharmaceutique : conformit\u00e9 EU GMP Annex 11 et FDA 21 CFR Part 11, principes ALCOA+ data integrity, validation syst\u00e8me (IQ\/OQ\/PQ), audit trail. Cadre ISO 22400-2:2014.","breadcrumb":{"@id":"https:\/\/teeptrak.com\/fr\/trs-industrie-pharmaceutique-gmp-2026\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/teeptrak.com\/fr\/trs-industrie-pharmaceutique-gmp-2026\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/teeptrak.com\/fr\/trs-industrie-pharmaceutique-gmp-2026\/#primaryimage","url":"https:\/\/teeptrak.com\/wp-content\/uploads\/2026\/05\/trs-industrie-pharmaceutique-gmp-2026.jpeg","contentUrl":"https:\/\/teeptrak.com\/wp-content\/uploads\/2026\/05\/trs-industrie-pharmaceutique-gmp-2026.jpeg","width":1150,"height":657,"caption":"TRS pharma 2026 : GMP + 21 CFR Part 11 + ALCOA+ data integrity | TeepTrak"},{"@type":"BreadcrumbList","@id":"https:\/\/teeptrak.com\/fr\/trs-industrie-pharmaceutique-gmp-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/teeptrak.com\/fr\/"},{"@type":"ListItem","position":2,"name":"TRS en industrie pharmaceutique 2026 : conformit\u00e9 GMP, 21 CFR Part 11 et data integrity"}]},{"@type":"WebSite","@id":"https:\/\/teeptrak.com\/fr\/#website","url":"https:\/\/teeptrak.com\/fr\/","name":"TEEPTRAK","description":"Optimisez votre potentiel industriel","publisher":{"@id":"https:\/\/teeptrak.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/teeptrak.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/teeptrak.com\/fr\/#organization","name":"TEEPTRAK","url":"https:\/\/teeptrak.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/teeptrak.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/teeptrak.com\/wp-content\/uploads\/2023\/05\/cropped-Capture-decran-2023-05-04-112832.png","contentUrl":"https:\/\/teeptrak.com\/wp-content\/uploads\/2023\/05\/cropped-Capture-decran-2023-05-04-112832.png","width":512,"height":512,"caption":"TEEPTRAK"},"image":{"@id":"https:\/\/teeptrak.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/teeptrak\/","https:\/\/www.linkedin.com\/company\/teeptrakinternational\/"]},{"@type":"Person","@id":"https:\/\/teeptrak.com\/fr\/#\/schema\/person\/e0b65287bf97c0856b9e70813a4b5aff","name":"\u00c9quipe TEEPTRAK","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/c15a5bed2b22793c34b357757ed5a12321e733893599e115e40c0263ef4877f7?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c15a5bed2b22793c34b357757ed5a12321e733893599e115e40c0263ef4877f7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c15a5bed2b22793c34b357757ed5a12321e733893599e115e40c0263ef4877f7?s=96&d=mm&r=g","caption":"\u00c9quipe TEEPTRAK"},"sameAs":["https:\/\/teeptrak.com"],"url":"https:\/\/teeptrak.com\/fr\/author\/auriane\/"}]}},"_links":{"self":[{"href":"https:\/\/teeptrak.com\/fr\/wp-json\/wp\/v2\/posts\/93701","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/teeptrak.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/teeptrak.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/teeptrak.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/teeptrak.com\/fr\/wp-json\/wp\/v2\/comments?post=93701"}],"version-history":[{"count":1,"href":"https:\/\/teeptrak.com\/fr\/wp-json\/wp\/v2\/posts\/93701\/revisions"}],"predecessor-version":[{"id":93702,"href":"https:\/\/teeptrak.com\/fr\/wp-json\/wp\/v2\/posts\/93701\/revisions\/93702"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/teeptrak.com\/fr\/wp-json\/wp\/v2\/media\/93695"}],"wp:attachment":[{"href":"https:\/\/teeptrak.com\/fr\/wp-json\/wp\/v2\/media?parent=93701"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/teeptrak.com\/fr\/wp-json\/wp\/v2\/categories?post=93701"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/teeptrak.com\/fr\/wp-json\/wp\/v2\/tags?post=93701"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}